NEW YORK TIMES CO-A (NYT)

US6501111073 - Common Stock

52.87  -0.4 (-0.75%)

After market: 52.873 +0 (+0.01%)

Fundamental Rating

7

Taking everything into account, NYT scores 7 out of 10 in our fundamental rating. NYT was compared to 92 industry peers in the Media industry. NYT gets an excellent profitability rating and is at the same time showing great financial health properties. NYT is not valued too expensively and it also shows a decent growth rate. With these ratings, NYT could be worth investigating further for quality investing!.



8

1. Profitability

1.1 Basic Checks

In the past year NYT was profitable.
In the past year NYT had a positive cash flow from operations.
NYT had positive earnings in each of the past 5 years.
NYT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

NYT has a better Return On Assets (10.14%) than 92.31% of its industry peers.
Looking at the Return On Equity, with a value of 15.12%, NYT belongs to the top of the industry, outperforming 83.52% of the companies in the same industry.
NYT has a Return On Invested Capital of 12.31%. This is amongst the best in the industry. NYT outperforms 92.31% of its industry peers.
NYT had an Average Return On Invested Capital over the past 3 years of 10.37%. This is above the industry average of 6.95%.
The last Return On Invested Capital (12.31%) for NYT is above the 3 year average (10.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROIC 12.31%
ROA(3y)8%
ROA(5y)7.01%
ROE(3y)12.79%
ROE(5y)11.57%
ROIC(3y)10.37%
ROIC(5y)9.39%

1.3 Margins

Looking at the Profit Margin, with a value of 11.04%, NYT belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Profit Margin of NYT has grown nicely.
NYT's Operating Margin of 14.00% is fine compared to the rest of the industry. NYT outperforms 78.02% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 49.02%, NYT is in line with its industry, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Gross Margin of NYT has declined.
Industry RankSector Rank
OM 14%
PM (TTM) 11.04%
GM 49.02%
OM growth 3Y6.86%
OM growth 5Y2.17%
PM growth 3Y19.5%
PM growth 5Y5.91%
GM growth 3Y1.67%
GM growth 5Y-4.97%

9

2. Health

2.1 Basic Checks

NYT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NYT has been reduced compared to 1 year ago.
Compared to 5 years ago, NYT has less shares outstanding
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 8.27 indicates that NYT is not in any danger for bankruptcy at the moment.
NYT has a better Altman-Z score (8.27) than 96.70% of its industry peers.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.27
ROIC/WACC1.34
WACC9.21%

2.3 Liquidity

NYT has a Current Ratio of 1.35. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
NYT has a Current ratio (1.35) which is in line with its industry peers.
A Quick Ratio of 1.35 indicates that NYT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.35, NYT is in line with its industry, outperforming 46.15% of the companies in the same industry.
The current and quick ratio evaluation for NYT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

5

3. Growth

3.1 Past

NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.84%, which is quite impressive.
NYT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.15% yearly.
The Revenue for NYT has decreased by -14.86% in the past year. This is quite bad
NYT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.77% yearly.
EPS 1Y (TTM)24.84%
EPS 3Y19.13%
EPS 5Y15.15%
EPS Q2Q%21.62%
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y10.8%
Revenue growth 5Y6.77%
Sales Q2Q%6.99%

3.2 Future

The Earnings Per Share is expected to grow by 12.95% on average over the next years. This is quite good.
NYT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.70% yearly.
EPS Next Y20.09%
EPS Next 2Y13.18%
EPS Next 3Y12.4%
EPS Next 5Y12.95%
Revenue Next Year6.44%
Revenue Next 2Y6.51%
Revenue Next 3Y6.26%
Revenue Next 5Y5.7%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.68, which means the current valuation is very expensive for NYT.
Compared to the rest of the industry, the Price/Earnings ratio of NYT is on the same level as its industry peers.
NYT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.17 indicates a quite expensive valuation of NYT.
NYT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, NYT is valued at the same level.
Industry RankSector Rank
PE 27.68
Fwd PE 25.17

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYT is on the same level as its industry peers.
NYT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.55
EV/EBITDA 17.97

4.3 Compensation for Growth

NYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of NYT may justify a higher PE ratio.
NYT's earnings are expected to grow with 12.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.38
PEG (5Y)1.83
EPS Next 2Y13.18%
EPS Next 3Y12.4%

5

5. Dividend

5.1 Amount

NYT has a yearly dividend return of 0.98%, which is pretty low.
Compared to an average industry Dividend Yield of 4.38, NYT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

On average, the dividend of NYT grows each year by 21.18%, which is quite nice.
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.18%
Div Incr Years6
Div Non Decr Years11

5.3 Sustainability

28.43% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
The dividend of NYT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.43%
EPS Next 2Y13.18%
EPS Next 3Y12.4%

NEW YORK TIMES CO-A

NYSE:NYT (12/20/2024, 8:04:00 PM)

After market: 52.873 +0 (+0.01%)

52.87

-0.4 (-0.75%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-04 2024-11-04/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners91.69%
Inst Owner Change-2.01%
Ins Owners0.68%
Ins Owner Change-0.21%
Market Cap8.67B
Analysts76
Price Target59.16 (11.9%)
Short Float %4.08%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Dividend Growth(5Y)21.18%
DP28.43%
Div Incr Years6
Div Non Decr Years11
Ex-Date10-09 2024-10-09 (0.13)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.26%
Min EPS beat(2)8.46%
Max EPS beat(2)10.06%
EPS beat(4)4
Avg EPS beat(4)23.07%
Min EPS beat(4)8.46%
Max EPS beat(4)55.15%
EPS beat(8)8
Avg EPS beat(8)30.32%
EPS beat(12)12
Avg EPS beat(12)29.68%
EPS beat(16)16
Avg EPS beat(16)31.53%
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)-0.64%
Revenue beat(8)3
Avg Revenue beat(8)-0.43%
Revenue beat(12)4
Avg Revenue beat(12)-0.49%
Revenue beat(16)8
Avg Revenue beat(16)-0.08%
PT rev (1m)2.2%
PT rev (3m)6.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.45%
EPS NY rev (1m)0.52%
EPS NY rev (3m)3.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 27.68
Fwd PE 25.17
P/S 3.42
P/FCF 23.55
P/OCF 21.93
P/B 4.68
P/tB 7.41
EV/EBITDA 17.97
EPS(TTM)1.91
EY3.61%
EPS(NY)2.1
Fwd EY3.97%
FCF(TTM)2.25
FCFY4.25%
OCF(TTM)2.41
OCFY4.56%
SpS15.47
BVpS11.3
TBVpS7.14
PEG (NY)1.38
PEG (5Y)1.83
Profitability
Industry RankSector Rank
ROA 10.14%
ROE 15.12%
ROCE 16.34%
ROIC 12.31%
ROICexc 15.92%
ROICexgc 26.79%
OM 14%
PM (TTM) 11.04%
GM 49.02%
FCFM 14.52%
ROA(3y)8%
ROA(5y)7.01%
ROE(3y)12.79%
ROE(5y)11.57%
ROIC(3y)10.37%
ROIC(5y)9.39%
ROICexc(3y)13.76%
ROICexc(5y)12.75%
ROICexgc(3y)21.31%
ROICexgc(5y)17.96%
ROCE(3y)13.77%
ROCE(5y)12.47%
ROICexcg growth 3Y22.23%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y7.2%
ROICexc growth 5Y-3.15%
OM growth 3Y6.86%
OM growth 5Y2.17%
PM growth 3Y19.5%
PM growth 5Y5.91%
GM growth 3Y1.67%
GM growth 5Y-4.97%
F-Score8
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 32.51%
Cap/Sales 1.07%
Interest Coverage 250
Cash Conversion 90.08%
Profit Quality 131.47%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 8.27
F-Score8
WACC9.21%
ROIC/WACC1.34
Cap/Depr(3y)43.76%
Cap/Depr(5y)52.33%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.73%
Profit Quality(3y)105.8%
Profit Quality(5y)136.75%
High Growth Momentum
Growth
EPS 1Y (TTM)24.84%
EPS 3Y19.13%
EPS 5Y15.15%
EPS Q2Q%21.62%
EPS Next Y20.09%
EPS Next 2Y13.18%
EPS Next 3Y12.4%
EPS Next 5Y12.95%
Revenue 1Y (TTM)-14.86%
Revenue growth 3Y10.8%
Revenue growth 5Y6.77%
Sales Q2Q%6.99%
Revenue Next Year6.44%
Revenue Next 2Y6.51%
Revenue Next 3Y6.26%
Revenue Next 5Y5.7%
EBIT growth 1Y10.06%
EBIT growth 3Y18.4%
EBIT growth 5Y9.09%
EBIT Next Year63.53%
EBIT Next 3Y25.32%
EBIT Next 5Y18.82%
FCF growth 1Y247.68%
FCF growth 3Y8.66%
FCF growth 5Y33.53%
OCF growth 1Y173.47%
OCF growth 3Y6.58%
OCF growth 5Y18.08%